BCG
DGX icon

Breakwater Capital Group’s Quest Diagnostics DGX Stock Holding History

Breakwater Capital Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.26M Sell
5,423
-50
-0.9% -$11.6K 0.15% 137
2026
Q2 		$1.16M Sell
5,473
-7
-0.1% -$1.37K 0.14% 155
2026
Q1 		$1.07M Buy
+5,480
New +$1.06M 0.14% 148

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

Breakwater Capital Group's DGX Position: Q3 2026 in Review

Breakwater Capital Group reduced its Quest Diagnostics (DGX) stake by 0.91% in Q3 2026, selling an estimated $11.6K and leaving 5,423 shares worth $1.26M. The position accounts for 0.15% of the portfolio, ranked #137.

Breakwater Capital Group first reported a position in DGX in Q1 2026 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Breakwater Capital Group held 5,423 shares of Quest Diagnostics worth $1.26M as of Q3 2026.
  • Breakwater Capital Group sold 50 Quest Diagnostics shares in Q3 2026, an estimated $11.6K.
  • Quest Diagnostics made up 0.15% of Breakwater Capital Group's portfolio in Q3 2026, its #137 holding.
  • Breakwater Capital Group first reported a position in Quest Diagnostics in Q1 2026 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Breakwater Capital Group's 13F filing for Q3 2026, filed 9 Oct 2026.